5 results match your criteria: "Center for Digital Health Stanford University Stanford CA.[Affiliation]"

Article Synopsis
  • Over the past 21 years, there has been a concerning rise in heart failure (HF)-related deaths among patients with atrial fibrillation (AF) in the U.S., with a total of 916,685 deaths recorded between 1999 and 2020.
  • The study revealed that age-adjusted mortality rates increased significantly, particularly after 2011, affecting men, White individuals, and those under 65 the most.
  • A notable spike in HF-related deaths was also seen during the first year of the COVID-19 pandemic, especially among patients with AF aged over 65.
View Article and Find Full Text PDF

Background: Heart failure disproportionately affects individuals residing in rural areas, leading to worse health outcomes. Digital health interventions have been proposed as a promising approach for improving heart failure management. This systematic review aims to identify randomized trials of digital health interventions for individuals living in underserved rural areas with heart failure.

View Article and Find Full Text PDF

Background Cardiovascular procedural treatments were deferred at scale during the COVID-19 pandemic, with unclear impact on patients presenting with non-ST-segment-elevation myocardial infarction (NSTEMI). Methods and Results In a retrospective cohort study of all patients diagnosed with NSTEMI in the US Veterans Affairs Healthcare System from January 1, 2019 to October 30, 2022 (n=67 125), procedural treatments and outcomes were compared between the prepandemic period and 6 unique pandemic phases: (1) acute phase, (2) community spread, (3) first peak, (4) post vaccine, (5) second peak, and (6) recovery. Multivariable regression analysis was performed to assess the association between pandemic phases and 30-day mortality.

View Article and Find Full Text PDF

Background Female sex is an independent predictor of stroke in patients with atrial fibrillation (AF). Older data suggest undertreatment with anticoagulation among women compared with men. However, it is unknown if novel therapies and updated guidelines have impacted sex differences in AF treatment and outcomes.

View Article and Find Full Text PDF